These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9608232)

  • 1. [Cytotoxic mechanism and antineoplastic action of etoposide].
    Dołega A
    Postepy Hig Med Dosw; 1998; 52(1):67-87. PubMed ID: 9608232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II.
    Treszezamsky AD; Kachnic LA; Feng Z; Zhang J; Tokadjian C; Powell SN
    Cancer Res; 2007 Aug; 67(15):7078-81. PubMed ID: 17671173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor).
    Chen Y; Su YH; Wang CH; Wu JM; Chen JC; Tseng SH
    Anticancer Res; 2005; 25(6B):4203-8. PubMed ID: 16309217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.
    Jarvis WD; Johnson CR; Fornari FA; Park JS; Dent P; Grant S
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1384-92. PubMed ID: 10454518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular response to etoposide treatment.
    Montecucco A; Biamonti G
    Cancer Lett; 2007 Jul; 252(1):9-18. PubMed ID: 17166655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
    Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent variable effects of etoposide on the cell cycle of CML cells.
    Fukumi S; Horiguchi-Yamada J; Iwase S; Ohno T; Yamada H
    Anticancer Res; 2000; 20(5A):3105-10. PubMed ID: 11062729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death.
    Sleiman RJ; Stewart BW
    Clin Cancer Res; 2000 Sep; 6(9):3756-65. PubMed ID: 10999770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.
    Facompré M; Wattez N; Kluza J; Lansiaux A; Bailly C
    Mol Cell Biol Res Commun; 2000 Jul; 4(1):37-42. PubMed ID: 11152626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
    Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K
    Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis is the most efficient death-pathway in tumor cells after topoisomerase II inhibition.
    El-Awady RA; Ali MM; Saleh EM; Ghaleb FM
    Saudi Med J; 2008 Apr; 29(4):558-64. PubMed ID: 18382799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of spin labeled derivatives of podophyllotoxin on cell cycle and macromolecular synthesis in human lymphoid leukemia Molt 4B cells.
    Wang JZ; Tsumura H; Shimura K; Tian X; Ito H
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):501-5. PubMed ID: 10437132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16).
    Tronov VA; Konoplyannikov MA; Nikolskaya TA; Konstantinov EM
    Biochemistry (Mosc); 1999 Mar; 64(3):345-52. PubMed ID: 10205305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
    Satterwhite DJ; White RL; Matsunami N; Neufeld KL
    Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 4-(4"-(2",2",6",6"-tetramethyl-1"-pipe-ridinyloxy) amino)-4'-demethylepipodophyllotoxin on nucleic acids, proteins, and DNA strand of L7712 cells in vitro].
    He XQ; Zhang PY; Tian X; Li JX
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):276-9. PubMed ID: 1442115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.
    Brel V; Annereau JP; Vispé S; Kruczynski A; Bailly C; Guilbaud N
    Biochem Pharmacol; 2011 Dec; 82(12):1843-52. PubMed ID: 21924246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
    Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
    J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.